- Supported exchanges /
- AU /
- ILA.AU
Island Pharmaceuticals Ltd (ILA AU) stock market data APIs
Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a collaboration agreement with Monash University and National Cancer Institute IND. It also has a cooperative research and development agreement with the U.S. Army, Island in preparation for its Phase 2a/b clinical study for ISLA-101. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.
Island Pharmaceuticals Ltd Financial Data Overview
| 0.078 | |
| 0.078 | |
| - | |
| 0.083 | |
| 0.077 | |
| 0.05-0.1 | |
| 9 897 K | |
| 127 M | |
| 1 252 K | |
| -0.02 | |
| 0.389 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Island Pharmaceuticals Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 252 K
- EBITDA 0
- Earnings Per Share -0.03
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Island Pharmaceuticals Ltd Earnings via APIs
- Latest Release 2023-02-23
- EPS/Forecast 0
Get Island Pharmaceuticals Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
